Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ichiro Nakashima

Showing results (1-10 of 250) with videos related to

Pageof 25
Sort By:
Brain and Nerve = Shinkei Kenkyu No Shinpo|May 17, 2023
[Therapeutic Strategies for Neuromyelitis Optica]Ichiro Nakashima
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2014
[Diagnostic criteria and differential diagnosis of neuromyelitis optica]Ichiro Nakashima
Brain and Nerve = Shinkei Kenkyu No Shinpo|January 8, 2020
[Prospects for Treatment of Neuromyelitis Optica Spectrum Disorder]Ichiro Nakashima
Brain and Nerve = Shinkei Kenkyu No Shinpo|November 9, 2013
[Molecular targeted therapy for neuroimmunological diseases]Ichiro Nakashima
Brain and Nerve = Shinkei Kenkyu No Shinpo|May 9, 2020
[Explanation of Multiple Sclerosis Diagnostic Criteria]Ichiro Nakashima
Journal of Neurology, Neurosurgery, and Psychiatry|July 8, 2017
Is MOG-IgG another biomarker for neuromyelitis optica?Ichiro Nakashima
Rinsho Shinkeigaku = Clinical Neurology|December 1, 2012
[Neuromyelitis optica]Ichiro Nakashima
Brain and Nerve = Shinkei Kenkyu No Shinpo|November 25, 2017
[Anti-MOG Antibody Associated Diseases]Ichiro Nakashima
Brain and Nerve = Shinkei Kenkyu No Shinpo|May 19, 2021
[Anti-Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease]Juichi Fujimori, Ichiro Nakashima
Journal of Neuroimmunology|January 3, 2024
Early-stage volume losses in the corpus callosum and thalamus predict the progression of brain atrophy in patients with multiple sclerosisJuichi Fujimori, Ichiro Nakashima
Pageof 25

Showing results (1-10 of 250) with videos related to

Sort By:
Pageof 25
Brain and Nerve = Shinkei Kenkyu No Shinpo|May 17, 2023
[Therapeutic Strategies for Neuromyelitis Optica]Ichiro Nakashima
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2014
[Diagnostic criteria and differential diagnosis of neuromyelitis optica]Ichiro Nakashima
Brain and Nerve = Shinkei Kenkyu No Shinpo|January 8, 2020
[Prospects for Treatment of Neuromyelitis Optica Spectrum Disorder]Ichiro Nakashima
Brain and Nerve = Shinkei Kenkyu No Shinpo|November 9, 2013
[Molecular targeted therapy for neuroimmunological diseases]Ichiro Nakashima
Brain and Nerve = Shinkei Kenkyu No Shinpo|May 9, 2020
[Explanation of Multiple Sclerosis Diagnostic Criteria]Ichiro Nakashima
Journal of Neurology, Neurosurgery, and Psychiatry|July 8, 2017
Is MOG-IgG another biomarker for neuromyelitis optica?Ichiro Nakashima
Rinsho Shinkeigaku = Clinical Neurology|December 1, 2012
[Neuromyelitis optica]Ichiro Nakashima
Brain and Nerve = Shinkei Kenkyu No Shinpo|November 25, 2017
[Anti-MOG Antibody Associated Diseases]Ichiro Nakashima
Brain and Nerve = Shinkei Kenkyu No Shinpo|May 19, 2021
[Anti-Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease]Juichi Fujimori, Ichiro Nakashima
Journal of Neuroimmunology|January 3, 2024
Early-stage volume losses in the corpus callosum and thalamus predict the progression of brain atrophy in patients with multiple sclerosisJuichi Fujimori, Ichiro Nakashima
Pageof 25